The U.S. Food and Drug Administration (FDA) has authorized the use of the first artificial intelligence (AI) drug-development tool for use in clinical trials of metabolic…
News
BILIARY ATRESIA
NewsLess invasive Kasai surgery works better for infants with BA: Study
Using a minimally invasive method called laparoscopy to conduct standard Kasai surgery significantly reduces blood loss and increases the chances of jaundice clearance compared with…
Major medical associations and state health departments are moving to maintain the standard of universal hepatitis B vaccination at birth, diverging from a recent…
CHOLANGITIS
NewsPSC-IBD study shows need for regional management guidelines
The frequency of primary sclerosing cholangitis (PSC) in people with inflammatory bowel disease (IBD) is lower in Asian countries than in the West, according…
CHOLESTASIS
NewsCommon virus may play a role in ICP development, study finds
Infection with human cytomegalovirus (HCMV), a common and usually harmless virus, may play a role in the development of intrahepatic cholestasis of pregnancy (ICP),…
FATTY LIVER DISEASE
NewsLower-cost TAEUS device tracks liver fat on par with gold standard
TAEUS, a diagnostic tool being developed by Endra Life Sciences, measures liver fat levels with similar accuracy to gold-standard tests, but with greater convenience…
ALAGILLE SYNDROME
NewsLivmarli helps ease stubborn itching in Alagille syndrome after surgery
Livmarli (maralixibat) safely eased severe, treatment-resistant itching in two girls with Alagille syndrome who previously underwent surgical biliary diversion (SBD), a procedure that…
People with hepatitis C who show higher values of liver scarring markers before starting antiviral therapy are significantly more likely to later develop…
The experimental oral therapy linerixibat from GlaxoSmithKline (GSK) offers rapid and sustained relief from severe itch in adults with primary biliary cholangitis (PBC),…
CHOLESTASIS
NewsTwo new USP53 gene mutations cause mild PFIC in Russian boy
Two new mutations in the USP53 gene were identified as the cause of a milder form of progressive familial intrahepatic cholestasis (PFIC), which resembled…
Recent Posts
- For girl in Asia, limited access to genetic testing delayed an Alagille diagnosis
- FDA gives bepirovirsen priority review for chronic hepatitis B
- Starting disease marker levels may shape Iqirvo response in PBC
- The possibility for liver function to improve brings me hope
- New mouse model could help guide PFIC3 treatment research